Eagle Pharmaceuticals
EGRX
#9984
Rank
S$20.35 M
Marketcap
$1.57
Share price
17.00%
Change (1 day)
-80.50%
Change (1 year)

Earnings for Eagle Pharmaceuticals (EGRX)

Earnings in 2023 (TTM): S$47.63 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's current earnings are S$0.25 Billion. In 2022 the company made an earning of S$88.46 Million, an increase over its 2021 earnings that were of -S$3.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eagle Pharmaceuticals from 2013 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) S$47.63 M-46.15%
2022 S$88.46 M-2361.45%
2021 -S$3.92 Million-111.53%
2020 S$33.91 M2.31%
2019 S$33.14 M-32.89%
2018 S$49.38 M-50.35%
2017 S$99.48 M38.63%
2016 S$71.75 M1966.43%
2015 S$3.47 M-111.46%
2014 -S$30.32 Million282.82%
2013 -S$7.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$23.42 B 48,813.32%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.60 B 11,596.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$18.31 B 38,151.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.38 Billion-890.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
S$6.28 B 13,021.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.63 B 28,365.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$11.26 Billion-23,597.57%๐Ÿ‡บ๐Ÿ‡ธ USA